Streamlining referrals by establishing a UAE-specific referral algorithm for CVD patients with overlapping COPD: a collaborative effort by cardiologists and pulmonologists
- PMID: 40630897
- PMCID: PMC12235745
- DOI: 10.3389/fcvm.2025.1531966
Streamlining referrals by establishing a UAE-specific referral algorithm for CVD patients with overlapping COPD: a collaborative effort by cardiologists and pulmonologists
Abstract
Introduction: Concomitant COPD and CVD are highly prevalent and contribute to increased risk of hospitalizations, morbidity, and mortality, and impose a significant financial burden on healthcare systems. Diagnosis of COPD in patients with comorbid CVD and vice versa is challenging due to an overlap between the risk factors and symptoms of these two conditions. This 8-member task force comprising pulmonologists and cardiologists agreed that in the UAE, while COPD patients suspected of having CVD are promptly referred to cardiology, CVD patients who may potentially also have COPD are often not referred or referred late from cardiology to pulmonology. This gap in identifying CVD patients who may potentially also have COPD must be addressed to facilitate referrals of such patients to pulmonology.
Methods and results: A task force comprising an equal number of cardiologists and pulmonologists met virtually and identified the gaps in current practices for diagnosing patients with comorbid COPD and CVD in the UAE. The task force has proposed an algorithm to expedite the referral of CVD patients suspected of COPD from cardiology to pulmonology.
Conclusion: Implementing this referral algorithm across all cardiology departments in the UAE can facilitate the diagnosis of COPD in CVD patients, allow timely treatment of COPD, and improve patient outcomes.
Keywords: COPD; United Arab Emirates; cardiologists; cardiovascular; collaboration; pulmonologists.
© 2025 Shehab, Alzaabi, Al Zubaidi, Mahboub, Skouri, Alhameli, El-Tamimi and Iqbal.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Global Initiative for Chronic Obstructive Lung Disease. 2024 GOLD report (2024). Available at: https://goldcopd.org/2024-gold-report/ (Accessed April 26, 2024).
-
- World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD) (2023). Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul... (Accessed April 26, 2024).
-
- Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. (2022) 10(5):447–58. 10.1016/S2213-2600(21)00511-7 - DOI - PMC - PubMed
-
- Chen S, Kuhn M, Prettner K, Yu F, Yang T, Bärnighausen T, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study. Lancet Glob Health. (2023) 11(8):e1183–93. 10.1016/S2214-109X(23)00217-6 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
